DRUG GUIDELINE

Dobutamine

SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, Coronory Care Unit

SCOPE (Staff): Medical, Nursing, Pharmacy

Printed versions of this document SHOULD NOT be considered up to date / current

Exclusions

Paediatrics (seek Paediatrician advice) and General Wards

Preamble

See Appendix 1 for full version of this Drug Guideline!

Contraindications

Adverse Effects

Related Documents

	CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
	CPG0195 - Intravenous Drug Infusion Preparation Guide For Adults In ICU, ED, Theatre And CVU
	CPP0544 - Intravenous Drug Administration And Classification List
	POL0077 - Medication Management
	CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
	SOP0001 - Principles Of Clinical Care

References

	Alfred Health (2008, November). Dobutamine (Acute) Infusion Drug Guideline. Alfred Health.
	MIMS Online. (2019, April). MIMS Online, DobutrexÂ® and Dobutamine hydrochloride injection (Abbott, Sandoz and DBL) product information. Retrieved April 21, 2019, from
	Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 21, 2019, from
	Safer Care Victoria. (2018, December). Dobutamine guideline. Retrieved April 13, 2019, from
	The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved April 21, 2019, from
	Therapeutic Guidelines Limited. (2019). Therapeutic Guidelines. Retrieved April 21, 2019, from
	Walters Kluwer. (2019) UpToDate, Drug Interaction section. Retrieved April 21, 2019, from

Appendix

Appendix 1 - Dobutamine

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 30/09/2020
Review Responsibility: Pharmacist - Rotational	Date for Review: 30/09/2024

Dobutamine - DRG0007 - Version: 5 - (Generated On: 24-05-2025 05:56)